We have read with great interest the article by Henderson and Miller regarding the endovascular management of dural carotid-cavernous fistulas with a transvenous approach via the superior ophthalmic vein [1] . An anterior orbitotomy allows the superior ophthalmic vein to be identified, and a venous catheter inserted and advanced into the cavernous sinus with a success rate for transvenous procedures reported at around 80% [1] . Carotid-cavernous fistulas are associated with a dilatation of the superior ophthalmic vein, however, challenges to their identification and cannulation arise in cases of small, fragile, anomalous or thrombosed veins [2] .
Based on our experience, we would like to report the use of an intraoperative Valsalva manoeuvre to assist cannulation of the superior ophthalmic vein. A 60-year-old gentleman underwent endovascular repair with a transvenous approach via the superior ophthalmic vein of a dural carotid-cavernous fistula. An anterior orbitotomy approach identified the superior ophthalmic vein, although cannulation proved challenging as the vein was small and fragile. An intraoperative anaesthetist controlled Valsalva manoeuvre was performed, which produced a prominent dilatation of the vein and enabled a successful cannulation. This technique may also be used to identify a small or anomalous superior ophthalmic vein.
Head and neck surgery may be associated with lifethreatening post-operative bleeding. Subsequently, numerous publications discuss intraoperative Valsalva manoeuvre and Trendelenburg positioning to assist identification of bleeding vessels [3, 4] . To our knowledge, this is the first report of intraoperative Valsalva manoeuvre used to assist ophthalmic vein cannulation, and hope this may be considered in similar challenging cases.
We appreciate the comments by Gout et al. [1] We agree that some superior ophthalmic veins are extremely fragile and difficult to cannulate, even with the available microcatheters (see supplemental video). We also agree that performing a Valsalva maneuver may make it easier to insert the microcatheter into the vessel. period but their visual acuity decreases after a few months of injury with the development of cataract [2, 4] . We saw six young patients in Kashmir valley in India over 2013-2017 developing bilateral electrical cataracts at our tertiary care centre. Three patients (labourers) had electrical injury while at work, whereas the other three had high voltage wires falling on them while walking on the street. In this part of the world, electricity runs via overhead wires that are uninsulated, increasing the chances of such electrical injury. All these patients were under 40 years of age. The cataracts formed were soft but total cataracts that could be easily aspirated providing good visual gain. All the patients had an entry and exit wound. One of the patients required an amputation of his hand while another had total loss of his ear lobe at the exit wound.
Electrical cataracts causing bilateral blindness at a young age is of great concern, as what we may be seeing is only part of a much bigger problem that needs to be tackled at its roots. Our apprehension lies in that such injuries are totally avoidable if an extra amount of care is taken while working at such high voltage currents and if overhead wires are properly insulated.
Electrical insults to the human body can result in a wide range of ocular injuries with resultant ocular complications An incidence of 6.2% of cataracts is reported following electric injury [4] .
Korn and Kikkawa [5] describe a patient post electrical injury with bilateral cataracts and optic atrophy with widespread macular pigment disruption who later developed retinal detachment causing permanent visual impairment. While none of our patients had retinal complications, one needs to follow up these cases over long term due to the potential of retinal detachments later on.
For the state of Kashmir which harbours one of the highest rates of blindness in India and is riddled with social conflict, government efforts need to be harnessed to prevent this public health issue. What we observed at our apex eye care centre could just be the tip of the iceberg.
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following cataract surgery. NICE guidance [2] comments that postoperative topical antibiotic prescribing is "part of standard practice" without advising it and recommending further research. Overall, 97% of ASCRS members use them [3] , and the version of Medisoft EPR used at my institution produces a prescription for a 2 week 'course' of antibiotics without prompting the surgeon to confirm the default position.
According to The Scottish Intercollegiate Guidelines Network [4] which covers ophthalmic as well as other disciplines of surgery, appropriate surgical prophylaxis is usually defined as a single peroperative dose though this can be extended to a maximum of 24 h for orthopaedic implants. Prolonged courses are thought to be unhelpful or deleterious though evidence for this in cataract surgery is lacking. Herrinton et al. [5] found that addition of postoperative topical antibiotics to an intracameral application increased the incidence of endophthalmitis (odds ratio of 1.6) though they commented on a possible lack of significance with only 11,000 patients in the intracameral only group.
The NICE request for further research is well made but surgeons can be reassured that endophthalmitis will not become much more common if they discontinue this probably inappropriate antibiotic prescribing as I did 15 years ago. Doing so could clarify this topic through our national dataset.
investigate this rate and factors associated with this condition using data collected from the published literature.
Methods
We performed a systematic review in multiple databases (including PubMed, MEDLINE, EMBASE, and Scopus) to Dec 20, 2017, to identify all case reports and case series describing patients co-infected by HIV and sporotrichosis. This systematic review was performed in accordance with the Preferred Reporting Items for a Systematic Review and Meta-analysis (PRISMA) [4] .
biopsy and/or exudate, cerebrospinal fluid, sputum, blood and synovial fluid). Patients demographic (gender, age and please residence), clinical characteristics (sporotrichosis clinical form, and the median CD4+ T-cell lymphocyte count) and microbial data were recorded. To assess the independent association between EE and characteristics of these patients, we compared patients with and without EE using univariate analysis with χ 2 and t tests. Statistical analysis was conducted using the PSS software (Chicago, IL, USA).
Results
A total of 43 publications reporting 65 individual case reports were included for data extraction and analysis (supplementary information) [1, 3, [5] [6] [7] . The EE rate in patients co-infected by HIV and sporotrichosis was 7.7% (7 eyes of 5 patients). Choroiditis was the most common clinical manifestation (5 eyes), followed by retinochoroiditis (1 eye), and granulomatous uveitis (1 eye). Culture of ocular specimens was Sporothrix positive in 1 of 5 patients with EE. All patients with EE had disseminated sporotrichosis. S. schenckii was causative fungus from all cases of the non-EE group (P < 0.0001) ( Table 1 ). There were no independent association in demographic characteristics, sporotrichosis clinical form, and the median CD4+ T-cell lymphocyte count between the patients with and without EE (P > 0.05) ( Table 1 ).
Discussion
Endophthalmitis due to Sporothrix species is extremely rare, with only few published case reports. This could have influenced on EE rate in patients co-infected by HIV and sporotrichosis, and our study could have either underestimated or overestimated the EE rate, resulting in possible bias. Therefore, EE rate in patients co-infected by HIV and sporotrichosis found in this study was low, it is less likely to recover Sporothrix fungus of ocular specimens, and there were no association between the clinical factors and EE. Although these findings limited, the development of EE only seems to be one of the manifestations of disseminated sporotrichosis in patients HIV-infected, therefore, betterdesigned studies with a well-selected population are essential. 
